000 01427 a2200421 4500
005 20250515020835.0
264 0 _c20060323
008 200603s 0 0 eng d
022 _a0022-3395
024 7 _a10.1645/GE-732R.1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLindsay, David S
245 0 0 _aBuprenorphine does not affect acute murine toxoplasmosis and is recommended as an analgesic in Toxoplasma gondii studies in mice.
_h[electronic resource]
260 _bThe Journal of parasitology
_cDec 2005
300 _a1488-90 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAcute Disease
650 0 4 _aAnalgesics, Opioid
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aBuprenorphine
_xpharmacology
650 0 4 _aCell Line
650 0 4 _aChlorocebus aethiops
650 0 4 _aCoccidiostats
_xpharmacology
650 0 4 _aDisease Models, Animal
650 0 4 _aFemale
650 0 4 _aMice
650 0 4 _aPain
_xetiology
650 0 4 _aSulfadiazine
_xpharmacology
650 0 4 _aToxoplasma
_xdrug effects
650 0 4 _aToxoplasmosis, Animal
_xcomplications
700 1 _aKaur, Taranjit
700 1 _aMitchell, Sheila M
700 1 _aGoodwin, David G
700 1 _aStrobl, Jeannine
700 1 _aDubey, J P
773 0 _tThe Journal of parasitology
_gvol. 91
_gno. 6
_gp. 1488-90
856 4 0 _uhttps://doi.org/10.1645/GE-732R.1
_zAvailable from publisher's website
999 _c16152742
_d16152742